Dr. Robert Froehlich - 05 Dec 2022 Form 4 Insider Report for HIGHLAND GLOBAL ALLOCATION FUND (HGLB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
06 Dec 2022, 16:22:36 UTC
Prior SEC filing
13 Oct 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Dr. Robert Froehlich

Key filing fact

Dr. Robert Froehlich filed Form 4 for HIGHLAND GLOBAL ALLOCATION FUND (HGLB) on 06 Dec 2022.

Key facts

  • This page summarizes Dr. Robert Froehlich's Form 4 filing for HIGHLAND GLOBAL ALLOCATION FUND (HGLB).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 06 Dec 2022, 16:22.

Change

  • Previous filing in this sequence was filed on 13 Oct 2021.
  • Current net transaction value: -$13,590.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HGLB transaction

Common Stock

Sale

Transaction value
$13,590
Shares
-1,391
Change %
-41%
Price
$9.77
Shares after
2,024
Date
05 Dec 2022
Ownership
See Footnote
Footnotes
F1
HGLB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,215
Date
05 Dec 2022
Ownership
See Footnote
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares are held by Mr. Froehlich through Mr. Froehlich's personal trust.

Footnote F2

These shares are held by Mr. Froehlich though Mr. Froehlich's SEP IRA Account.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .